Publication | Closed Access

Electropharmacologic effects and pharmacokinetics of almokalant, a new class III antiarrhythmic, in patients with healed or healing myocardial infarcts and complex ventricular arrhythmias

Electrophysiological EvaluationHeart FailureCardiogenic ShockCardiovascular DiseaseMedicineMyocardial InfarctsArrhythmiaCardiovascular PharmacologyComplex Ventricular ArrhythmiasPharmacotherapyElectrophysiologyPublic HealthPharmacologyCardiologyElectropharmacologic EffectsAnesthesiologyCardiac Arrest